Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Cash Flows

v3.26.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Cash flows from operating activities:    
Loss from continuing operations $ (6,511,348) $ (2,595,687)
Adjustments to reconcile net loss from continuing operations to net cash used in operating activities - continuing operations:    
Depreciation and amortization 157,926 203,801
Noncash lease expense 91,389 91,387
Stock-based compensation expense 3,595,744 175,493
Provision for doubtful accounts 142,618 13,986
Loss on seizure of cash 0 184,055
Unrealized loss on investment 44,000 0
Loss on disposal of property, plant and equipment 0 2,024
Changes in operating assets and liabilities, net of effects of discontinued operations:    
Accounts receivable 268,400 (98,597)
Prepaid expenses and other current assets (195,989) 159,089
Accounts payable 582,216 (369,194)
Accrued expenses 469,681 (3,996)
Other current liabilities 24,946 0
Lease liability (108,457) (106,006)
Deferred revenue (648,769) (157,805)
Net cash used in operating activities - continuing operations (2,087,643) (2,501,450)
Net cash used in operating activities (2,087,643) (2,501,450)
Cash flows from investing activities:    
Costs incurred to develop technology 0 (242,020)
Purchases of property and equipment (3,995) (20,873)
Payments to acquire investments (1,300,000) (700,000)
Purchases of intangible assets (3,700,000)
Net cash used in investing activities - continuing operations (5,003,995) (962,893)
Net cash used in investing activities (5,003,995) (962,893)
Cash flows from financing activities:    
Proceeds from the sale of Common Stock 6,052,746 4,485,717
Proceeds from (Repayment of) short-term debt 774,691 0
Proceeds from Noncontrolling Interests 0 82,140
Net cash provided by financing activities - continuing operations 6,827,437 4,567,857
Net cash provided by financing activities 6,827,437 4,567,857
Net (decrease) increase in cash, cash equivalents, and restricted cash (264,201) 1,103,514
Cash, cash equivalents, and restricted cash, beginning of period 1,731,155 627,641
Cash, cash equivalents, and restricted cash, end of period 1,466,954 1,731,155
Supplemental disclosures of other cash flow information:    
Non-cash amortization of commitment funding 187,500 375,000
Acquisition of DTT Tokens 2,593,780 0
Conversion of Note Payable into Common Stock [Member]    
Supplemental disclosures of other cash flow information:    
Conversion from Note Payable to Common Stock 157,887 0
Copyrights [Member]    
Supplemental disclosures of other cash flow information:    
Non-cash stock issuance 3,233,828 0
Non-cash stock issuance 3,233,828 0
Remote More [Member]    
Supplemental disclosures of other cash flow information:    
Non-cash stock issuance 300,000 0
Non-cash stock issuance 300,000 0
Commitment Funding [Member]    
Supplemental disclosures of other cash flow information:    
Non-cash stock issuance 0 0
Non-cash stock issuance 0 0
Acquisition Stock Issuance [Member]    
Supplemental disclosures of other cash flow information:    
Non-cash stock issuance 0 0
Non-cash stock issuance 0 0
QBSG Limited Investment [Member]    
Supplemental disclosures of other cash flow information:    
Non-cash stock issuance 0 500,000
Non-cash stock issuance $ 0 $ 500,000